Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

Journal of General Internal Medicine

Volumn 21, Issue 2, 2006, Pages 193-195

  Gowing, Linda R ^a,e   Farrell, Michael ^b   Bornemann, Reinhard ^c   Sullivan, Lynn E ^d   Ali, Robert L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BIELEFELD UNIVERSITY   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Drug & Alcohol Services South Australia   (Australia)

Author keywords

HIV infections: prevention and control; Methadone: therapeutic use; Opioid related disorders: drug therapy; Substance abuse, intravenous: drug therapy

Indexed keywords

METHADONE; OPIATE;

CLINICAL TRIAL; CONDOM; DATA BASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG ABUSE; DRUG DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; REVIEW; SUBSTITUTION THERAPY; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

HIV INFECTIONS; HUMANS; METHADONE; NARCOTICS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33644838923     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2005.00287.x     Document Type: Review

References (29)

1. Gowing L Farrell M Bornemann R Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection [Cochrane Review] In The Cochrane Library Issue 4 Chichester, UK John Wiley & Sons 2004
2. Centre for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003. Atlanta: U.S. Department of Health and Human Services, 2004. Available from
3. Dolan KA Shearer J MacDonald M Mattick RP Hall W Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system Drug Alcohol Depend 2003 72 59 65
4. Sees KL Delucchi KL Masson C et al Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence a randomized controlled trial JAMA 2000 283 1303 10
5. Camacho LM Bartholomew NG Joe GW Cloud MA Simpson DD. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance Drug Alcohol Depend 1996 41 1 7
6. Chatham LR Hiller ML Rowan-Szal GA Joe GW Simpson DD. Gender differences at admission and follow-up in a sample of methadone maintenance clients Subst Use Misuse 1999 34 1137 65
7. Gossop M Marsden J Stewart D Rolfe A. Patterns of improvement after methadone treatment 1 year follow-up results from the National Treatment Outcome Research Study (NTORS) Drug Alcohol Depend 2000 60 275 86
8. King VL Kidorf MS Stoller KB Brooner RK. Influence of psychiatric comorbidity on HIV risk behaviors changes during drug abuse treatment J Addict Dis 2000 19 65 83
9. Magura S Siddiqi Q Freeman RC Lipton DS. Changes in cocaine use after entry to methadone treatment J Addict Dis 1991 10 31 45
10. Batki SL Sorensen JL Gibson DR Maude-Griffin P. HIV-infected i.v. drug users in methadone treatment outcome and psychological correlates - a preliminary report NIDA Res Monogr 1989 95 405 6
11. Brooner R Kidorf M King V Beilenson P Svikis D Vlahov D. Drug abuse treatment success among needle exchange participants Public Health Rep 1998 113 129 39
12. Kwiatkowski CF Booth RE. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users J Acquir Immune Defic Syndr 2001 26 483 9
13. Simpson DD Joe GW Rowan-Szal G Greener J. Client engagement and change during drug abuse treatment J Subst Abuse 1995 7 117 34
14. Strang J Marsden J Cummins M et al Randomized trial of supervised injectable versus oral methadone maintenance report of feasibility and 6-month outcome Addiction 2000 95 1631 45
15. Meandzija B O'Connor PG Fitzgerald B Rounsaville BJ Kosten TR. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users Drug Alcohol Depend 1994 36 109 13
16. Metzger DS Woody GE McLellan AT et al Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment an 18-month prospective follow-up J Acquir Immune Defic Syndr 1993 6 1049 56
17. Grella CE Anglin D Rawson R Crowley R Hasson A. What happens when a demonstration project ends. Consequences for a clinic and its clients J Subst Abuse Treat 1996 13 249 56
18. Margolin A Avants SK Warburton LA Hawkins KA Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users Health Psychol 2003 22 223 8
19. Stark K Muller R Bienzle U Guggenmoos-Holzmann I. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin J Epidemiol Community Health 1996 50 534 7
20. Thiede H Hagan H Murrill CS. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area J Urban Health 2000 77 331 45
21. Abbott PJ Weller SB Delaney HD Moore BA. Community reinforcement approach in the treatment of opiate addicts Am J Drug Alcohol Abuse 1998 24 17 30
22. Avants SK Margolin A Sindelar JL et al Day treatment versus enhanced standard methadone services for opioid-dependent patients a comparison of clinical efficacy and cost Am J Psychiatry 1999 156 27 33
23. Baker A Kochan N Dixon J Wodak A Heather N. HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment Addiction 1995 90 545 54
24. Moss AR Vranizan K Gorter R Bacchetti P Watters J Osmond D. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990 AIDS 1994 8 223 31
25. Williams AB McNelly EA Williams AE D'Aquila RT. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users AIDS Care 1992 4 35 41
26. Serpelloni G Carrieri MP Rezza G Morganti S Gomma M Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users a nested case-control study AIDS Care 1994 6 215 20
27. Marsch LA Bickel WK Badger GJ Jacobs EA. Buprenorphine treatment for opioid dependence the relative efficacy of daily, twice and thrice weekly dosing Drug Alcohol Depend 2005 77 195 204
28. Mattick RP Breen C Kimber J Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence Cochrane Library 2002
29. Mattick RP Kimber J Breen C Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence Cochrane Database Syst Rev 2003 CD002207